Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
06/17/1998 | EP0847391A1 Aromatic compounds and pharmaceutical compositions containing them |
06/17/1998 | EP0847277A1 Treatment of ocular inflammatory conditions with interleukin-10 |
06/17/1998 | EP0636142B1 Lactam peptides having hle inhibiting activity |
06/17/1998 | EP0635003B1 Perhydroisoindole derivatives as p substance antagonists |
06/17/1998 | EP0580633B1 Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract |
06/17/1998 | CN1184644A External application tincture named |
06/17/1998 | CN1038751C Cyclopeptides |
06/16/1998 | US5767120 Antiinflammatory agents, antiallergens; treatment for septic shock |
06/16/1998 | US5767088 Useful for treating pain, inflammation, smooth muscle contraction and inducing vasodilation |
06/16/1998 | US5767075 Inhibiting protein interactions |
06/16/1998 | US5767069 Cyclosporins |
06/16/1998 | US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases |
06/16/1998 | US5766886 Modified antibody variable domains |
06/16/1998 | US5766610 Useful for treatment of mammalian skin and hair, rheumatism, resipiratory system disorder, cardiovascular and vision disorders |
06/16/1998 | US5766593 Anti-inflammatory CD14 peptides |
06/16/1998 | US5766591 Methods and compositions useful for inhibition of angiogenesis |
06/16/1998 | US5766585 Infecting bone marrow cells with recombinant retroviral expression vector that contains a polynucleotide sequence coding a biologically active interleukin receptor antagonist protein, injecting into host; antiinflammatory agents |
06/16/1998 | CA2165779C Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
06/16/1998 | CA2132831C Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans |
06/16/1998 | CA2003718C Compounds |
06/11/1998 | WO1998024916A1 Novel calpaines, production and use thereof |
06/11/1998 | WO1998024905A2 Secreted proteins and polynucleotides encoding them |
06/11/1998 | WO1998024902A1 Adaptor protein frs2 and related products and methods |
06/11/1998 | WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
06/11/1998 | WO1998024804A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
06/11/1998 | WO1998024797A1 Antisense inhibition of human adhesion molecules |
06/11/1998 | WO1998024794A1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS |
06/11/1998 | WO1998024793A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity |
06/11/1998 | WO1998024783A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
06/11/1998 | WO1998024782A2 Substituted pyrimidine compounds and their use |
06/11/1998 | WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use |
06/11/1998 | WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
06/11/1998 | WO1998024763A2 Immunotherapeutic imides/amides as pde iv and tnf inhibitors |
06/11/1998 | WO1998024762A1 Vitamin d3 derivatives |
06/11/1998 | WO1998024759A1 Metalloproteinase inhibitors |
06/11/1998 | WO1998024477A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
06/11/1998 | WO1998024463A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
06/11/1998 | WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
06/11/1998 | WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases |
06/11/1998 | CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases |
06/11/1998 | CA2274304A1 Novel calpaines, production and use thereof |
06/11/1998 | CA2274250A1 Inhibitors of interleukin-1.beta. converting enzyme |
06/11/1998 | CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme |
06/11/1998 | CA2274145A1 Adaptor protein frs2 and related products and methods |
06/11/1998 | CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
06/11/1998 | CA2274023A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity |
06/11/1998 | CA2274019A1 Phenyl glyoxamides as spla2 inhibitors |
06/11/1998 | CA2273850A1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
06/11/1998 | CA2273845A1 Secreted proteins and polynucleotides encoding them |
06/11/1998 | CA2273203A1 Antisense inhibition of human adhesion molecules |
06/11/1998 | CA2273002A1 Immunotherapeutic imides/amides as pde iv and tnf inhibitors |
06/11/1998 | CA2272148A1 Vitamin d3 derivatives |
06/11/1998 | CA2224334A1 Self-enhancing, pharmacologically controllable expression systems |
06/11/1998 | CA2224131A1 Novel human 11 cb splice variant |
06/10/1998 | EP0846762A2 Novel V31 seven transmembrane receptors |
06/10/1998 | EP0846689A1 Benzimidazole compounds |
06/10/1998 | EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors |
06/10/1998 | EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists |
06/10/1998 | EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists |
06/10/1998 | EP0845984A1 Use of aminoadamantane compounds as immunoregulators |
06/10/1998 | EP0831817A4 Antigen-processing cell-targeted conjugates |
06/10/1998 | EP0693054B1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors |
06/10/1998 | CN1184483A Fucopeptides |
06/10/1998 | CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
06/10/1998 | CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use |
06/09/1998 | US5763673 Diarylheptanoide derivative and pharmaceutical composition comprising the same |
06/09/1998 | US5763621 Reaction of acid compound with hydroxylamine compound or amidation of acid |
06/09/1998 | US5763614 1,4-dihydropyridine derivatives and methods of producing the same |
06/09/1998 | US5763611 Treating osteoporosis, rheumatoid arthritis |
06/09/1998 | US5763582 Derivatives of triterpenoid acids and uses thereof |
06/09/1998 | US5763571 Amino acid sequences which inhibit binding |
06/09/1998 | US5763567 Human amino acid sequences which can bind to and/or neutralize heparin |
06/09/1998 | US5763487 Skin disorders, cardiovascular disorders and cosmetics |
06/09/1998 | US5763479 Naphthoquinone derivatives for the treatment of chronic inflammation |
06/09/1998 | US5763452 Nonsteroid antiarthritic antiinflammatory agents |
06/09/1998 | US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus |
06/09/1998 | US5763220 Human apoptosis-related calcium-binding protein |
06/09/1998 | US5762936 Antioxidant derived from lentil and its preparation and uses |
06/09/1998 | US5762935 Anti-inflammatory and infection protective effects of sesamin-based lignans |
06/09/1998 | US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
06/04/1998 | WO1998023644A1 Peptide derivatives |
06/04/1998 | WO1998023636A1 Heptapeptide oxytocin analogues |
06/04/1998 | WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
06/04/1998 | WO1998023565A2 Aminoguanidines and alkoxyguanidines as protease inhibitors |
06/04/1998 | WO1998009948A3 Nitric ester derivatives and their use in urinary incontinence and other diseases |
06/03/1998 | EP0845535A2 Leader peptidase (lep) from Streptococcus |
06/03/1998 | EP0845263A1 Capsules containing diclofenac or salts thereof in solution |
06/03/1998 | EP0845035A2 Urocortin peptides |
06/03/1998 | EP0845034A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
06/03/1998 | EP0845002A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
06/03/1998 | EP0844875A2 Use of basic amino acids and derivatives for lowering ceramide levels |
06/03/1998 | EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS |
06/03/1998 | EP0844873A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
06/03/1998 | EP0683767B1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists |
06/03/1998 | EP0509984B1 Method of preparing lysozyme dimers |
06/03/1998 | CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies |
06/03/1998 | CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
06/03/1998 | CN1183784A Peptides and remedy for autoimmune diseases comprising same |
06/03/1998 | CN1183781A Novel heterocyclic compounds |
06/03/1998 | CN1183774A Trisubstd phenyl derivs |